Clinical Research Directory
Browse clinical research sites, groups, and studies.
MMA Embolization for Refractory Chronic Migraine
Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Summary
This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
Official title: Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-04-23
Completion Date
2029-05-15
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Interventions
Middle Meningeal Artery embolization
Bilateral middle meningeal artery embolization using TRUFILL n-BCA liquid embolic system
Locations (7)
Hartford Hospital
Hartford, Connecticut, United States
University of Buffalo Medical Center
Buffalo, New York, United States
Mount Sinai
New York, New York, United States
Stony Brook University Medical Center
Stony Brook, New York, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Semmes Murphey Foundation
Memphis, Tennessee, United States
West Virginia University
Morgantown, West Virginia, United States